Corbenic Partners’s Merck MRK Stock Holding History

Corbenic Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$25K	Sell	269 -389	-59%	-$34.5K	0.01%	89
2022 Q1	$54K	Sell	658 -83,537	-99%	-$6.59M	0.01%	76
2021 Q4	$6.51M	Buy	84,195 +5,464	+7%	+$435K	1.26%	26
2021 Q3	$5.96M	Buy	78,731 +5,464	+7%	+$416K	1.45%	24
2021 Q2	$5.75M	Buy	73,267 +4,172	+6%	+$310K	1.51%	21
2021 Q1	$5.12M	Buy	69,095 +10,987	+19%	+$810K	1.31%	23
2020 Q4	$4.57M	Buy	58,108 +714	+1%	+$54.6K	1.89%	20
2020 Q3	$4.58M	Buy	57,394 +300	+0.5%	+$23.5K	2.2%	11
2020 Q2	$4.25M	Sell	57,094 -414	-0.7%	-$31.2K	2.33%	11
2020 Q1	$4.25M	Buy	57,508 +8,595	+18%	+$675K	3.28%	8
2019 Q4	$4.27M	Buy	+48,913	New	+$4.02M	3.1%	10
2017 Q4	$2M	Buy	37,001 +637	+2%	+$35.3K	2.52%	17
2017 Q3	$2.22M	Sell	36,364 -266	-0.7%	-$16.1K	2.93%	16
2017 Q2	$2.24M	Sell	36,630 -4,658	-11%	-$284K	3.11%	14
2017 Q1	$2.5M	Sell	41,288 -43,001	-51%	-$2.61M	3.07%	15
2016 Q4	$4.74M	Sell	84,289 -1,292	-2%	-$75.6K	5.07%	6
2016 Q3	$5.1M	Sell	85,581 -9,235	-10%	-$540K	5.41%	6
2016 Q2	$5.21M	Sell	94,816 -5,859	-6%	-$312K	5.34%	6
2016 Q1	$5.08M	Buy	100,675 +1,847	+2%	+$90.5K	5.18%	7
2015 Q4	$4.98M	Buy	98,828 +8,099	+9%	+$408K	4.78%	9
2015 Q3	$4.28M	Buy	90,729 +7,692	+9%	+$409K	3.87%	10
2015 Q2	$4.51M	Buy	83,037 +82,779	+32,085%	+$4.64M	3.85%	7
2015 Q1	$14K	Hold	258	–	–	0.01%	102
2014 Q4	$14K	Buy	+258	New	+$14.4K	0.01%	112
2014 Q1	–	Sell	-49,377	Closed	-$2.36M	–	116
2013 Q4	$2.36M	Sell	49,377 -1,603	-3%	-$73.3K	2.24%	15
2013 Q3	$2.32M	Hold	50,980	–	–	3.09%	12
2013 Q2	$2.26M	Buy	+50,980	New	+$2.28M	2.11%	19

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Corbenic Partners's MRK Position: Q2 2022 in Review

Corbenic Partners reduced its Merck (MRK) stake by 59% in Q2 2022, selling an estimated $34.5K and leaving 269 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #89.

Corbenic Partners first reported a position in MRK in Q2 2013 and has held it in 27 quarters since. The position peaked at $6.51M in Q4 2021. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

Corbenic Partners held 269 shares of Merck worth $25K as of Q2 2022.
Corbenic Partners sold 389 Merck shares in Q2 2022, an estimated $34.5K.
Merck made up 0.01% of Corbenic Partners's portfolio in Q2 2022, its #89 holding.
Corbenic Partners first reported a position in Merck in Q2 2013 and has held it in 27 quarters since.
Corbenic Partners's Merck position peaked at $6.51M in Q4 2021.
3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Corbenic Partners's 13F filing for Q2 2022, filed 25 Jul 2022.